Roberts Zachary
Officer at ALLO
- Sold, on record
- $185k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Feb 2, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ALLOAllogene Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ALLONoticeJan 21, 2025 2025
Filed to sell 27,199 shares ($48k)
Roberts Zachary, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale ALLONo planJan 21, 2025 same day
Sold 27,199 shares at $1.78 ($48k)
Roberts Zachary, EVP of R&D
No 10b5-1 planSold 5.3% of holdings ($917k position)488,054 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice ALLONoticeFeb 3, 2025 +13 days
Filed to sell 18,832 shares ($32k)
Roberts Zachary, Officer
No 10b5-1 planFiling
- 4 Form 4 sale ALLONo planFeb 3, 2025 same day
Sold 18,832 shares at $1.70 ($32k)
Roberts Zachary, EVP of R&D
No 10b5-1 planSold 2.8% of holdings ($1.1M position)643,135 shares leftFollows a Form 144Filing
- 5 Form 144 notice ALLONoticeJan 21, 2026 +352 days
Filed to sell 26,269 shares ($41k)
Roberts Zachary, Officer
No 10b5-1 planFiling
- 6 Form 4 sale ALLONo planJan 21, 2026 same day
Sold 26,269 shares at $1.56 ($41k)
Roberts Zachary, EVP of R&D
No 10b5-1 planSold 4.1% of holdings ($1M position)616,866 shares leftFollows a Form 144Filing
- 7 Form 144 notice ALLONoticeFeb 2, 2026 +12 days
Filed to sell 35,700 shares ($63k)
Roberts Zachary, Officer
No 10b5-1 plan1.4x usual sizeFiling
- 8 Form 4 sale ALLONo planFeb 2, 2026 same day
Sold 35,700 shares at $1.77 ($63k)
Roberts Zachary, EVP of R&D
No 10b5-1 planSold 5.8% of holdings ($1.1M position)581,166 shares left1.4x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 4, 2026 | ALLO | EVP of R&D | Form 4 sale | 35,700 | $63k | 5.8% | No plan | SEC |
| Feb 2, 2026 | Feb 2, 2026 | ALLO | Officer | Form 144 notice | 35,700 | $63k | Notice | SEC | |
| Jan 21, 2026 | Jan 23, 2026 | ALLO | EVP of R&D | Form 4 sale | 26,269 | $41k | 4.1% | No plan | SEC |
| Jan 21, 2026 | Jan 21, 2026 | ALLO | Officer | Form 144 notice | 26,269 | $41k | Notice | SEC | |
| Feb 3, 2025 | Feb 5, 2025 | ALLO | EVP of R&D | Form 4 sale | 18,832 | $32k | 2.8% | No plan | SEC |
| Feb 3, 2025 | Feb 3, 2025 | ALLO | Officer | Form 144 notice | 18,832 | $32k | Notice | SEC | |
| Jan 21, 2025 | Jan 23, 2025 | ALLO | EVP of R&D | Form 4 sale | 27,199 | $48k | 5.3% | No plan | SEC |
| Jan 21, 2025 | Jan 21, 2025 | ALLO | Officer | Form 144 notice | 27,199 | $48k | Notice | SEC | |
| Jan 22, 2024 | Jan 22, 2024 | ALLO | Officer | Form 144 notice | 24,690 | $78k | Notice | SEC |